NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $76.92 +0.09 (+0.12%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$76.83 -0.09 (-0.12%) As of 05/22/2026 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Solventum Stock (NYSE:SOLV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Solventum alerts:Sign Up Key Stats Today's Range$75.91▼$77.5050-Day Range$62.49▼$76.9252-Week Range$62.38▼$88.20Volume1.63 million shsAverage Volume1.61 million shsMarket Capitalization$13.32 billionP/E Ratio9.43Dividend YieldN/APrice Target$84.25Consensus RatingModerate Buy Company Overview Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota. Read More Solventum Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreSOLV MarketRank™: Solventum scored higher than 61% of companies evaluated by MarketBeat, and ranked 355th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingModerate Buy Consensus RatingSolventum has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 8 buy ratings, 5 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Solventum is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageSolventum has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Solventum's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.37% Earnings GrowthEarnings for Solventum are expected to grow by 8.37% in the coming year, from $6.57 to $7.12 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Solventum is 9.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.03.Price to Earnings Ratio vs. SectorThe P/E ratio of Solventum is 9.43, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 21.01.Price to Earnings Growth RatioSolventum has a PEG Ratio of 1.19. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSolventum has a P/B Ratio of 2.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Solventum's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.75% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 6.42.Change versus previous monthShort interest in Solventum has recently increased by 1.58%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolventum does not currently pay a dividend.Dividend GrowthSolventum does not have a long track record of dividend growth. News and Social Media1.8 / 5News Sentiment-0.10 News SentimentSolventum has a news sentiment score of -0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Solventum this week, compared to 5 articles on an average week.Search InterestOnly 7 people have searched for SOLV on MarketBeat in the last 30 days. This is a decrease of -13% compared to the previous 30 days.MarketBeat Follows4 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Solventum insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,344.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders0.24% of the stock of Solventum is held by insiders.Percentage Held by InstitutionsSolventum has minimal institutional ownership at this time.Read more about Solventum's insider trading history. Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SOLV Stock News HeadlinesSolventum Corporation (NYSE:SOLV) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesMay 25 at 2:14 AM | americanbankingnews.comSolventum Shareholders Back Board, Pay and Auditor ChoicesMay 20, 2026 | tipranks.comGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.May 25 at 1:00 AM | Behind the Markets (Ad)What are Wall Street analysts' target price for Solventum stock?May 19, 2026 | msn.comWedbush initiates coverage of Solventum (SOLV) with outperform recommendationMay 16, 2026 | msn.comTarget the Red-Hot Spin-Off and Merger Space With These ETFs (SOLV)Spin-offs and mergers can lead to major movement for share prices, but accessing these scenarios can be challenging for investors; these ETFs can help.May 16, 2026 | marketbeat.comSolventum’s Q1 Earnings Call: Our Top 5 Analyst QuestionsMay 15, 2026 | finance.yahoo.comSOLV Energy, Inc. (MWH) Q1 2026 Earnings Call TranscriptMay 15, 2026 | seekingalpha.comSee More Headlines SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $79.25 on January 1st, 2026. Since then, SOLV stock has decreased by 2.9% and is now trading at $76.9230. How were Solventum's earnings last quarter? Solventum Corporation (NYSE:SOLV) released its earnings results on Tuesday, May, 5th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.35 by $0.13. The business's quarterly revenue was down 3.0% on a year-over-year basis. Read the conference call transcript. How will Solventum's stock buyback program work? Solventum's Board of Directors approved a stock buyback program on Thursday, November 20th 2025, which allows the company to buy back $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 7.5% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its shares are undervalued. Who are Solventum's major shareholders? Solventum's top institutional shareholders include Bank of America Corp DE (0.83%), Arrowstreet Capital Limited Partnership (0.51%), Bank of New York Mellon Corp (0.45%) and Dimensional Fund Advisors LP (0.45%). View institutional ownership trends. How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Solventum own? Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AUO (AUOTY). Company Calendar Last Earnings5/05/2026Today5/25/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 SOLV's financial health is in the Red zone, according to TradeSmith. SOLV has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNYSE:SOLV Previous SymbolNYSE:SOLV CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployees20,000Year Founded2023Price Target and Rating Average Price Target for Solventum$84.25 High Price Target$103.00 Low Price Target$50.00 Potential Upside/Downside+9.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)$8.16 Trailing P/E Ratio9.43 Forward P/E Ratio11.71 P/E Growth1.19Net Income$1.56 billion Net Margins17.33% Pretax Margin20.47% Return on Equity23.51% Return on Assets7.63% Debt Debt-to-Equity Ratio0.96 Current Ratio1.07 Quick Ratio0.75 Sales & Book Value Annual Sales$8.33 billion Price / Sales1.60 Cash Flow$9.00 per share Price / Cash Flow8.55 Book Value$28.69 per share Price / Book2.68Miscellaneous Outstanding Shares173,180,000Free Float172,759,000Market Cap$13.32 billion OptionableOptionable Beta0.59 Social Links 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NYSE:SOLV) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
